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Abstract
CD8
+ tumor infiltrating T cells (TIL) lack effector-phase functions due to defective proximal TCR-mediated signaling
previously shown to result from inactivation of p56
lck kinase. We identify a novel interacting partner for p56
lck in nonlytic
TIL, Protocadherin-18 (‘pcdh18’), and show that pcdh18 is transcribed upon in vitro or in vivo activation of all CD8
+ central
memory T cells (CD44
+CD62L
hiCD127
+) coincident with conversion into effector memory cells (CD44
+CD62L
loCD127
+).
Expression of pcdh18 in primary CD8
+ effector cells induces the phenotype of nonlytic TIL: defective proximal TCR signaling,
cytokine secretion, and cytolysis, and enhanced AICD. pcdh18 contains a motif (centered at Y842) shared with src kinases
(QGQYQP) that is required for the inhibitory phenotype. Thus, pcdh18 is a novel activation marker of CD8
+ memory T cells
that can function as an inhibitory signaling receptor and restrict the effector phase.
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Introduction
CD8
+ CTL play an essential role in killing of virus-infected and
transformed cells but in unmanipulated hosts fail to control tumor
growth. Although the frequency of antigen-specific T cells in
cancer patients is low, demonstrable priming occurs in response to
tumorgrowth[1].Investigationofanimalmodelsandtumor-bearing
patients show production of antigen-specific CTL in the periphery
but whose effector phase T cell function is suppressed upon entrance
to the tumor [2,3], a phenotype postulated to contribute to tumor
escape from immune-mediated eradication [4]. This implies the
tumor microenvironment induces TIL lytic dysfunction, a conclu-
sion that was substantiated by several experimental approaches [5].
In a murine model of colorectal carcinoma (MCA38) nonlytic TIL
were shown to be recently-activated effector memory cells
(CD44
+CD62L
loCD69
+CD95L
+CD122
+CD127
+ [6]). The dys-
functional lytic phenotype was subsequently shown to be due to a
tumor-induced block in proximal TCR-mediated signaling that
obviates ZAP70 activation, inturn due to rapid inactivation of p56
lck
upon contact with cognate tumor cells [7]. During analysis of TIL
p56
lck we observed that when nonlytic TIL form conjugates ex vivo
with cognate tumor cells, p56
lck co-immuneprecipitates with a
120 kD protein, but whose identity and potential role in regulation
of TIL function was unknown.
We have identified this novel p56
lck interacting partner: the
adhesion molecule Protocadherin-18 (‘pcdh18’). We show that in
cells of the hematopoietic lineage pcdh18 is expressed in activated
central memory CD8
+ T cells (CD44
hiCD62L
hiCD127
hi) coinci-
dent with differentiation to the effector memory phenotype:
CD8
+CD44
+CD62L
loCD127
hi. pcdh18 is expressed in endoge-
nous CD8
+ memory cells that accumulate as mice age, or those
elicited by prior immunization with various antigens. In addition,
transfection of pcdh18 into primary CD8
+ T cells (which do not
express pcdh18) imparts the nonlytic TIL phenotype: defective
proximal signaling, loss of effector phase functions, and AICD.
Thus, these data reconcile prior observations concerning p56
lck
activation status in TIL [5,7] and identifies a novel activation
marker of CD8
+ effector memory T cells which can also function
as a negative regulator of proximal TCR signaling and therein
effector phase function.
Results
Identification of a p56
lck binding protein in TIL
Analysis of p56
lck activation status in nonlytic TIL by
immuneprecipitation and reciprocal immunoblotting using Ab
reactive with the phosphorylated form of the src family kinase
inhibitory motif (centered on Y505) showed that this motif in
p56
lck was not appreciably phosphorylated upon conjugation in
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weight band (,120 kD) co-immuneprecipitated with p56
lck and
was recognized by motif-specific anti-pY505. The equivalent
experiment using TIL that were briefly cultured in vitro before
analysis (and therefore had re-established proximal TCR signaling
and lytic function [5]), showed the presence of the 120 kD band
but its abundance and conjugation-dependent phosphorylation
was dramatically reduced compared to nonlytic TIL (Fig. 1a,
lower panel). (Regulation of p56
lck centered on motifs Y394 and
Y505 is shown diagrammatically in Fig. 1b). Since anti-peptide Ab
may have significant non-specific crossreactivity, this analysis was
repeated using anti-pY Ab (4G10) and produced equivalent results
(Fig. 1c). A trivial possible basis for this observation (dimerization
of p56
lck during cell lysis) was eliminated by reciprocal immuno-
blotting using a second Ab for blotting that is reactive with a
different epitope of p56
lck which did not detect the ,120 kD
protein (Fig. 1d).
These observations implied that a ,120 kD protein: interacts
with p56
lck in nonlytic TIL, contains the epitope recognize by anti-
pY505, and is rapidly tyrosine phosphorylated upon contact with
cognate tumor cells. BLAST analysis performed using as search
query the p56
lck inhibitory motif peptide sequence to which anti-
pY505 was raised (EGQYQPQP) identified a gene containing the
sequence: QGQYQPRP; Protocadherin-18 (‘pcdh18’, [8]). Se-
quence comparison of protocadherin and related cadherin gene
families revealed that pcdh18 is the only protocadherin member
that contains a Y residue in the context of a Q/P motif (Fig. 2a)
and also is the only non-src gene in the database to contain the src
inhibitory motif. Expression of pcdh18 was examined by RT-PCR
analysis of various tissues and analyzed closely-related pcdh genes
for specificity control (pcdh8, Fig. 2b and pcdh12, Fig. 2d. qPCR
primer sequences are listed in Table 1). pcdh18 RNA is widely
expressed in adult tissues (and is expressed in cognate MCA38
tumor, dns), whereas expression of other pcdh genes is more
restricted.
In order to identify the spleen cell type that expresses pcdh18,
purified splenocytes from young control mice were analyzed by
RT-PCR in comparison to nonlytic TIL and the CD8
+ T cell line
CTLL-2 (Fig. 2c). No signal was detected from major cell types
including NK cells (even after activation when lytic function and
IFN expression is high, Fig. S2. A modest PCR signal was detected
in CD11c
+ bone marrow-derived DC that increased upon
activation, Fig. S1c). Cells isolable with the spleen capsule express
pcdh18 (Fig. S1a) possibly accounting for the PCR signal obtained
from total spleen preparations. To determine if pcdh18 expression
was a function of activation status, CD8
+ spleen cells from young
naı ¨ve mice were treated with ConA but found to be negative
(Fig. 2c). Nonlytic CD8
+ TIL express pcdh18 RNA immediately
upon isolation whose levels undulate with time of cell activation in
vitro (Fig. 2d). Purified from the same tumor as CD8
+ TIL, CD4
+
TIL do not express pcdh18 (Fig. S2). Inhibitory signaling receptor
PD-1 RNA is not detected in nonlytic TIL but is induced after
brief culture in vitro, as is its ligand PD-1L.
We considered the possibility that the differentiation status of
spleen cells may account for the inconsistent PCR findings and
next compared FACS-purified CD4
+, CD8
+, CD11c
+, and CD45
+
cells from young (4 week) and aged (.48 weeks) control mice using
qRT-PCR (Fig. 2e). CD8
+ T cells of aged mice contain pcdh18
RNA and, since older mice contain a greater percentage of
memory T cells compared to younger mice, prompted consider-
ation that pcdh18 is expressed in CD8
+ memory cells. Further
supporting this notion is the previous observation that TIL are
effector memory cells [6].
pcdh18 is expressed in memory T cells
A memory response was induced by either: infection with Listeria
monocytogenes (and clearance), injection of allogeneic splenocytes (H-
2D), or inoculation of a sub-tumorigenic dose of a transplantable
syngeneic tumor (EL-4). At different times post antigen exposure (3
weeks up to .50 weeks) spleen total CD8
+ T cells were isolated
and pcdh18 expression analyzed. Expression of pcdh18 was low
but in cells from immunized mice was rapidly and robustly
increased upon in vitro activation (Fig. 3a). Induction started ,2h
post activation and by ,24 h expression was reduced close to that
of non-activated cells. The rapid kinetics and transient nature of
induction in cells following development of memory due to antigen
exposure suggests pcdh18 is an immediate-early response gene of
the memory response.
CD8
+ T cells isolated following primary in vivo treatment express
low levels (Fig. 3b) in comparison to re-activation of a memory
response, approximately 6-fold less. Additionally, mice were
infected with L. monocytogenes (or injected with allogeneic spleen
cells, dns) to establish memory and subsequently challenged in vivo
(Fig. 3c, pcdh18 expression in CD8
+ TIL is shown at one time
point for comparison). After priming by infection and resting
before re-challenge (for more than four months in this case),
pcdh18 was rapidly and robustly induced in total CD8
+
splenocytes upon in vivo challenge showing that pcdh18 expres-
sion is not a phenomenon restricted to the in vitro experimental
model. Control age-matched mice given only challenge (‘prima-
ry’) showed minimal pcdh18 expression reinforcing the notion
that pcdh18 is expressed in memory CD8
+ T cells. Transcrip-
tional regulation of expression following in vivo re-activation, by
either re-infection with L. monocytogenes (Fig. 3c) or re-injection of
allogeneic cells (dns) demonstrates the physiological relevance of
pcdh18 expression. (CD4
+ T cells were also isolated from these
groups of mice and did not express pcdh18 RNA, dns. Expression
was never detected in CD4
+ T cells, either TIL, naive or memory
cells, Fig. 2c and Fig. S2). Expression of pcdh18 in CD8
+ cells of
naive mice following activation in vitro was assessed in comparison
to selected cytokines- Fig. 3d). pcdh18 is not appreciably
expressed in activated naive CD8
+ T cells. Characteristic of
naive cells, expression of effector phase cytokine RNAs is minimal
until late in activation at which point IFN is robustly transcribed
(Fig. 3d).
Analysis of pcdh18 expression in memory cells
In order to determine if pcdh18 is preferentially expressed in
cells of a given differentiation state, CD8
+ central memory T cells
(‘Cm’, CD44
hiCD62L
hiCD127
+) were FACS-purified from young
(4 weeks), aged (ca 1 year), or mice that had been infected with L.
monocytogenes .10 months prior (‘memory’). Central memory cells
represented the major population of CD8
+CD44
hi cells and
effector memory cells were ,4% of cells respectively in each
group of mice (Fig. 4a). Preliminary experiments suggested that
upon activation of purified Cm cells in vitro, pcdh18 was expressed
starting at ,2 h coincident with conversion to the effector
memory phenotype (loss of CD62L). To extend those observa-
tions, following in vitro activation of endogenous Cm, Cm and Em
cells were purified by FACS before RNA analysis by qRT-PCR
(Fig. 4b+c). Selected FACS data for young mice is shown in
Fig. 4b where a reciprocal relation is seen between decreased
recovery of Cm cells and increased Em cells (as a percentage of
live cells) as a function of time of activation. The number of Cm
and Em cells recovered at various times after activation in vitro
was plotted as a ratio of Cm to Em cells (‘Cm/Em conversion’,
Fig. 4c). Aged mice had greater starting numbers of Cm cells,
thus the ratio is initially higher for that group, but rate of loss of
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groups. For all groups of mice the percentage of Cm cells
declined steeply at early times of activation (Fig. 4c). Conversion
of Cm (CD62L
hi)t oE m( C D 6 2 L
lo) cells after in vitro activation
likely reflects a combination of factors (including death) but
primarily differentiation.
Figure 1. Reciprocal immunoblot analysis of p56
lck isolated from nonlytic and lytic MCA38 TIL. (1a) TIL were purified as described in [6]
and either immediately used to form conjugates with MCA38 cells for the indicated times (upper panel) or plated in complete RPMI medium (lower
panel) until performance of conjugation and reciprocal immunoblotting. Following incubation, detergent lysates were prepared and
immuneprecipitated with Ab reactive with an epitope in the amino terminal portion of the protein (clone 3A5). Immuneprecipitated p56
lck was
subjected to immunoblotting using anti-p56
lck (pY505) and detected by chemiluminescence following reaction with peroxidase-conjugated anti-
rabbit. (1b) Schematic diagram of p56
lck. The two primary sites of p56
lck regulation- the kinase activation motif (centered at Y394) and the inhibitory
motif (centered at Y505) are indicated by boxes and key regulators of Y phosphorylation at each site are indicated. ‘+’ and ‘2’ indicate whether a
given enzyme causes activation or inhibition of p56
lck activity. Activation of kinase function is mediated by phosphorylation of Y394 which is
autophosphorylated upon dephosphorylation of Y505 (by CD45). Once phosphorylated, control of kinase function is mediated by Shp-1
dephosphorylation of Y394. Phosphorylation of Y505 (by Csk) prevents autophosphorylation of Y394 and Csk activity is controlled by cAMP
regulation of PKA activity. The amino acid sequence of the Y505 motif is also indicated. (1c) Reciprocal immunoblot analysis of p56
lck using anti-pY
Ab. TIL:MCA38 conjugates were formed for the indicated times as described above, extracts were prepared and immuneprecipitated with anti-p56
lck
(Ab 3A5), and blotted with anti-pY (4G10). The position of mouse IgG (the species used for p56
lck immuneprecipitation, indicated as ‘mIgG’, and
which obscures p56
lck) is validated by analysis of purified mouse IgG in the last gel lane and the arrowhead indicates the interacting protein detected
by anti-pY blotting. (1d) High mw band is not p56
lck dimer. Substitution of anti-pY505 with an anti-p56
lck reactive to a different p56
lck epitope than
3A5 (Ab 2102) was performed and detected only p56
lck migrating at the appropriate mw, and not a higher molecular weight species, eliminating the
possibility that the higher mw band represented dimeric p56
lck.
doi:10.1371/journal.pone.0036101.g001
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following in vitro activation of endogenous Cm cells is shown in
Fig. 5a. Even after activation for extended time Cm cells from
each model expressed comparatively low levels of pcdh18 RNA. In
contrast, Em cells of aged and memory mice express robust levels
even at the earliest activation time (2 h). The pattern of expression
Figure 2. RT-PCR analysis of protocadherin 18 in tissues and immune cells. (2a) Amino acid sequence comparison of the p56
lck Y505 motif
in protocadherins. (2b) RT-PCR analysis of mouse tissues. The indicated tissues and organs were isolated from a control mouse, RNA was extracted
and used to prepare cDNA, and PCR performed using control (pcdh8 and b-actin) or pch18 primers as described in ‘Materials and Methods’. (2c) RT-
PCR analysis of spleen cells. Spleens were isolated from a 7 week old mouse and the indicated cells were purified by FACS (top panel). TIL were
isolated from an MCA38 tumor. CTLL-2 is a CD8
+ lytic cell line. RNA was isolated and used to program RT-PCR as described in ‘Materials and Methods’.
Similarly spleen CD8
+ T cells were purified and activated in vitro with anti-CD3 for the indicated times before analysis (bottom panel). (2d) TIL qRT-PCR
analyses. Single cell suspensions of MCA38 tumors were prepared and CD4
+ or CD8
+ TIL were isolated by magnetic immunobeading. (Liver tissue was
isolated and used for RNA isolation in certain control analyses. TIL were labeled with anti-CD4 or CD8 Ab and further purified by FACS (example of
flow cytometry analysis shown in left panels) before RNA isolation and qRT-PCR analysis. TIL used to prepare RNA immediately after isolation are
indicated in as ‘nonlytic’ or ‘TIL 0 hr’. As indicated some TIL samples were cultured in vitro for 8 or 24 h before RNA isolation during which time TIL
recover both proximal TCR-mediated signaling and lytic function [5,7]. PCR analyses of various target RNAs are shown and include several control
reactions that demonstrate specificity of the expression patterns observed (e.g. pcdh18 and pcdh12 in CD8
+ TIL, Dab1 and Dab2a in CD8
+ TIL,
granzyme B in CD8
+ TIL and liver, as well as TNF, IFN, IL-2, PD-1, and PD-1L). Data show SD from three independent experiments. (2e) qRT-PCR analysis
of purified spleen cells. Spleen immune cells were isolated by FACS from young (4 week) or old (.48 week) control mice and RNA was isolated and
used to program pcdh18 qRT-PCR as described in ‘Materials and Methods’. The data shown are representative of multiple repetitions.
doi:10.1371/journal.pone.0036101.g002
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aged mice levels undulated over the assay period with maxima
approximately every 6 h. This temporal pattern reflects expression
as determined by gene array analysis performed on a separate
biological sample of Cm cells from aged mice (Fig. 5a, bottom
panel). [In the array analysis Cm cells were activated in vitro but
were not re-purified (to eliminate Em cells) before RNA isolation
and thus contain CD62L
lo cells that differentiate in vitro under
these conditions.]
The high level of expression of IFN, IL-2 and grzB in newly-
differentiated Em cells from mice in which a memory response was
deliberately induced (by L. monocytogenes infection, Fig. S3) supports
the notion that CD44
hiCD62L
loCD127
hi cells in immune (‘mem-
ory’) mice contain bona fide Em cells and young mice do not. Cm
cells (CD62L
hiCD127
hi) show an obverse pattern of those
cytokines associated with the effector phase. Collectively consid-
ered, pcdh18 is expressed relatively poorly in Cm cells and in Em
cells the kinetics of expression closely follows the pattern of grzB,
IFN, and IL-2 which is consistent with the notion that pcdh18
expression is restricted to recently activated Em cells.
In order to evaluate the expression of pcdh18 in a different
population of memory cells total CD8
+ T cells from bone marrow
were analyzed (Fig. 5b). pcdh18 expression trended with
paradigmatic RNAs of memory cells (IFN and grzB) in that
expression was greater in old versus young mice supporting the
generality of our findings.
pcdh18 expression in primary CD8
+ lytic T cells
Spleen cells activated in vitro with anti-CD3 (followed by IL-2
treatment) expand a population of CD8
+CD44
hi cells coincident
with development of lytic function (Fig. 6a) [9]. (Interestingly,
these cells resemble memory cells in terms of being
CD62L
hiCD127
+ and upon activation resemble Em cells in that
they start to lose expression of CD62L). Since these cells do not
contain pcdh18 RNA (Fig. 3d), in order to assess the effect of
pcdh18 expression on effector phase function, pcdh18 was
expressed in these cells. A cDNA encoding pcdh18 was obtained
from a TIL library, sequenced and found to be in agreement with
the published sequence (dns). An Ab raised to a recombinant
cytoplasmic domain of pcdh18 used in reciprocal immunoblotting
of TIL extracts (Fig. 6b top) confirmed the identity of pcdh18
(Fig. 1a). Expression of pcdh18 protein in transfected primary lytic
effector cells was confirmed by flow cytometry analysis of where
,32% of PI
2CD8
+ lytic effector cells are pcdh18
+ (Fig. 6b).
Cells transfected with control vector form prominent clusters
upon activation ,24 h post transfection (Fig. 6c). The number
and size of clusters in control plasmid transfected cells increased
with culture time reflecting cell division. However, cells transfected
with pcdh18 form dramatically fewer and smaller clusters implying
an effect on activation. Expression of pcdh18 containing a point
mutation in the src inhibitory domain homology (QGQYQP,
Y842F) completely reverses the effect on cluster formation
implying phosphorylation of the motif is important in pcdh18
function (see below). Similarly, expression of cytokine RNA in
pcdh18-transfected cells was significantly diminished compared to
controls (Fig. 6d). (Cytokine PCR analyses of nonlytic and lytic
TIL is shown for comparison.) Further, analysis of AICD in
pcdh18-expressing cells (bottom panels in Fig. 6d) showed a
dramatic reduction in both cell recovery and viability: cells
expressing pcdh18 are more Annexin V
+ (early apoptosis, dns) and
PI
+/Annexin V
+ (late apoptosis, Fig. 6d). (The induction of AICD
by pcdh18 expression in primary T cells and high-density culture
is reminiscent of PD-1 which upon ligation and TCR activation
also causes AICD [10–12]). Similar to the effect on cluster
formation, expression of the Y842F mutant significantly reverses
enhanced AICD caused by wt pcdh18. In addition, more cells are
recovered when transfected cells are not activated in vitro (dns)
showing a requirement for activation in induction of cell death.
Expression of pch18 in primary effector cells also inhibited
cytolysis (Fig. 6e), calcium flux (dns), and activation of Zap70
(Fig. 6f) confirming a site of action in the proximal TCR pathway.
Similar to TIL or transfected primary CD8
+ T cells (though less
robustly) CD44
+CD62L
+pcdh18
+ endogenous Cm cells in aged
mice have diminished calcium flux and Zap70 activation
compared to CD44
2 naı ¨ve cells derived from the same mouse
(Fig. S4b). Wildtype pcdh18 was shown to bind to p56
lck (Fig. 1)
and phosphorylation of Y842 is required for inhibition of T cell
functions (Fig. 6). Thus, pcdh18 is a strong candidate to mediate
the effector phase defects in nonlytic TIL since each of these
characteristic biochemical and functional deficiencies in transfect-
ed primary effector cells phenocopy nonlytic TIL [5–7,13,14].
Table 1. Primers for qPCR.
GENE 59R39 SEQUENCE qPCR Ta
PD-1L FW CCACGGAAATTGTCTGGTTG 60
PD-1L RV TGCTGCATAATCAGCTACGG 60
PCDH-19 FW ACCATCACTTGTCTCCTCGGCTGT 58
PCDH-19 RV CGTCCCGAGGTACAAGGCGG 58
DAB-2b FW CACTGATACCAGCCAATCCC 58
DAB-2b RV AATCAAGCTTGCAAGAGATTTGT 58
DAB1 RV ACCAGCGCCAAGAAAGACT 58
DAB1 FW ATCAGCTTGGCTTTGACCG 58
PCDH-12 FW GTGAGGGGCAATGACAATCT 56
PCDH-12 RV GAAGAGCTGTCGAGCCTGTT 56
PD-1 FW CAGGCTGGGTAGAAGGTGAG 60
PD-1 RV CATTCACTTGGGCTGTGCT 60
IFN FW AGCAACAGCAAGGCGAAAA 58
IFN RV CTGGACCTGTGGGTTGTTGA 58
GRANZYME-B FW CATGTAGGGTCGAGAGTGGG 58
GRANZYME-B RV CCTCCTGCTACTGCTGACCT 58
IL-2 FW GTGCTCCTTGTCAACAGCG 58
IL-2 RV GGGGAGTTTCAGGTTCCTGTA 58
DAB2a RV AAGTCATGCTGGCTCCACAG 58
DAB2a FW CACTGATACCAGCCAATCCC 58
GAPDH FW TGTGTCCGTCGTGGATCTGA 56
GAPDH RV CCTGCTTCACCACCTTCTTGA 56
TNF FW AGAGGCACTCCCCCAAAAGAT 58
TNF RV GCAGGAATGAGAAGAGGCTGA 58
PCDH-18 FW TTTGGGGCGCGATTCTCCGA 56
PCDH-18 RV GGACTCTGCACTCCTCCGTA 56
PCDH-8 FW ATCTCGGGCCGAGAAGCTGA 56
PCDH-8 RV CGGGGACACGTATCTGCTAC 56
b-ACTIN FW CCGTGAAAAGATGACCCAGATC 56
b-ACTIN RV CATACCCAGGAAGGAAGGCTG 56
(Ta=annealing temperature).
doi:10.1371/journal.pone.0036101.t001
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The cell surface adhesion molecule pcdh18 is expressed widely
in tissues but in the hematopoietic system primarily in CD8
+
effector memory T cells (CD8
+CD44
+CD62L
loCD127
+) derived
from recently-activated central memory cells
(CD8
+CD44
+CD62L
hiCD127
+). pcdh18 binds to p56
lck in acti-
vated primary CD8
+ effector memory cells and is closely
associated with defective: cytokine secretion, cytolysis, and
blockade of proximal TCR signaling, and enhanced AICD; a
phenotype that mimics that of nonlytic TIL [5,7]. These effects are
characteristic of inhibitory signaling receptors (ISR) expressed in
NK cells and T cells that function to dampen cellular immune
responses [11,15–17].
p56
lck in CD8
+ TIL interacts with pcdh18 coincident with
robust phosphorylation at a tyrosine motif (Y842) shared with src
kinases (QGQYQP). Y842 was shown by site-directed mutagenesis
to be required for the pcdh18 inhibitory phenotype in transfected
T cells. At early times during cell interaction the equivalent motif
in p56
lck (Y505) is not phosphorylated [5]. Since Csk is known to
phosphorylate p56
lck Y505, we hypothesize that it is responsible
for the preferential phosphorylation of the homologous motif in
pcdh18 (Figure S6). Supporting this notion is co-localization of
Csk and p56
lck at the TIL immunological synapse [7] where, since
pch18 and p56
lck interact (Fig. 1), it is reasonable to assume
pcdh18 is also localized. The rapidity of inhibition of TCR
signaling mediated by pcdh18 is characteristic of ISR expressed in
immune cells, thus, within seconds of recognition of cognate tumor
cell, p56
lck in anti-MCA38 TIL becomes inactive, therefore Zap70
is not activated and all downstream signaling is prevented which
abrogates the effector phase. Although many studies have shown
that a wide variety of inhibitory signaling receptors are expressed
in cells of the adaptive immune response [16,18], this is the first
report of the adhesion molecule pcdh18 both being expressed in T
cells and regulating proximal TCR signaling.
Figure 3. RNA analyses of spleen cells after induction of memory in vivo. (a) qRT-PCR analysis of spleen CD8
+ T cells isolated from BL/6 mice
previously infected with either 5,000 recombinant Listeria monocytogenes, buffer controls, or EL4 cells at a subtumorigenic dose (‘regressor tumor’).
28 days after exposure spleen CD8
+ T cells were purified, activated in vitro with Con A for the indicated times, RNA prepared and qRT-PCR performed
as described in ‘Materials and Methods’. (This analysis has been performed using mice previously infected for times up to 1 year with similar results).
Insert shows gel analysis of pcdh18 RT-PCR expression from L. monocytogenes-immune mice. (3b) qRT-PCR analysis of purified CD8
+ T cells from mice
injected with L. monocytogenes or allogeneic H-2D spleen cells. (3c) qRT-PCR analysis of purified CD8
+ T cells from mice originally infected with L.
monocytogenes which were challenged by in vivo infection by L. monocytogenes. Spleens were isolated at the indicated times following challenge.
Age-matched naive mice received only primary exposure given at the time of secondary challenge. Nonlytic TIL are shown for comparison. (3d) qRT-
PCR analysis of purified control CD8
+ spleen T cells and activated in vitro with anti-CD3e for the indicated times before RNA isolation and analysis by
qRT-PCR. The data shown are representative of multiple repetitions.
doi:10.1371/journal.pone.0036101.g003
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+ CD44
hiCD62L
loCD127
hi (Effector-
memory) and CD44
hiCD62L
hiCD127
hi (Central-memory) cells obtained from young (,5 week) and .50 week old naı ¨ve, and 50 week old mice that
were previously injected with allogeneic spleen cells as indicated. Following sorting, an aliquot of cells was immediately taken for RNA isolation
without activation. Analyses in the left panels are gated on CD8
+ cells and show the distribution of CD44
+ cells. Analyses in the right panels show Em
and Cm cells within the CD44
lo and CD44
hi populations as indicated. (4b) Cm and Em cells were isolated by FACS from young, old, and memory (L.
monocytogenes-infected) mice and activated in vitro with ConA for the indicated times before qRT-PCR. The % of CD8
+CD44
hi cells as CD62L
loCD127
hi
(Em) and CD62L
hiCD127
hi (Cm from the ‘young’ cohort are shown in tabular form in this figure. Flow cytometry analyses of some samples from the
kinetic experiment are shown to illustrate gating. (4c) Enriched CD8
+ spleen cells prior to sorting are shown in the left panels. After labeling Cm were
isolated and activated in vitro. The recovery of Em and Cm cells was determined by flow cytometry after re-staining and flow cytometric analysis.
Shown are the FACS analyses after the indicated times of Cm activation. Also shown is the number of Cm and Em cells derived from in vitro activation
of Cm cells represented as a ratio of Cm to Em cells at the various times of analyses.
doi:10.1371/journal.pone.0036101.g004
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36101Since a role for pcdh18 in the immune system was not
previously reported, by RT-PCR we determined its expression
profile in CD8
+ cells in different states of differentiation finding its
expression is restricted to memory cells and is not unique to a
particular experimental model including endogenous cells from
aged naı ¨ve mice. The experiment in which Cm cells were purified
and activated in vitro before purification of Em and Cm cells
followed by RT-PCR analysis (Fig. 5) showed that neither Cm or
Em originating from young mice robustly express pcdh18, in
contrast to in vitro differentiated Em cells originating from aged
mice. Perhaps there exists in young mice an endogenous
CD44
hiCD62L
hiCD127
+ Cm subpopulation that resists pcdh18
transcriptional activation under our ex vivo activation conditions.
Alternatively, and more likely, memory cells identified by cell
surface marker expression contain non-memory cells in addition to
bona fide memory cells. We hypothesize that pcdh18 expression
distinguishes the true memory population. In that experiment Cm
cells from aged mice rapidly convert to Em cells (loss of CD62L)
and the Em robustly express pcdh18 in an undulating kinetic
pattern seen also by gene array analysis (Fig. 5a). The rapid
kinetics of pcdh18 transcription induction in vitro or in vivo (Fig. 3c)
further implies a role in memory re-activation.
That pcdh18 is a marker of Em formation is also supported by
several observations including the robust expression in activated
bone marrow-derived CD8
+ T cells (Fig. 5b) and in isolated TIL.
Further evidence that pcdh18 is a marker of authentic memory
cells comes from the experiment in which TIL were adoptively
transferred into RAG 2/2 mice (Fig. S4). Adoptive transfer of
naı ¨ve cells into RAG 2/2 causes homeostatic expansion in which
naı ¨ve cells acquire a cell surface phenotype that resembles central
memory cells (CD8
+CD44
+CD62L
hiCD127
+) but these cells likely
do not provide memory-mediated immune protection reflected by
the lack of expression of IFN upon isolation. In contrast, IFN
expression is extant (and able to be further induced) in cells
derived from adoptive transfer of TIL, which do not express IFN
in primary tumor tissue. pcdh18 transcription in adoptive
transferred TIL and not in T cells derived from naı ¨ve cells (90
days post transfer into RAG 2/2) after in vitro activation confirms
that pcdh18 expression is exclusive to CD8
+ T cells that have been
previously activated, i.e. bona fide memory cells.
To define the signature of CD8
+ Cm T cells during
differentiation into Em cells, we profiled the gene expression
patterns of purified Cm cells during the early stage of in vitro
activation by microarray (Figure S5). Activation of Cm cells
resulted in differential expression of many genes whose expression
clustered into five groups each having distinct kinetics (Figure S5).
The clusters containing the largest numbers of active genes had
their maximal expression at 8 and 20 hours of activation and
cluster 4 (having the third largest number of genes, and which
contains pcdh18), has maxima at both 8 and 20 hours of
activation. The profiles of Cm cells at each time point of
activation (2–24 h) were compared to non-activated cells and the
normalized expression array data of all 5,274 ‘‘active genes’’ (see
‘Materials and Methods’) are shown in Figure S6. Expression
levels of selected genes from different clusters which have been
validated (in Fig. S3) are shown in Figure S9.
The undulating kinetics of pcdh18 expression (peaking twice
within 24 h) is shared by 972 genes (by cluster analysis, Fig. S5),
which are nearly 20% of all active genes. This gene cluster
(number 4) includes a candidate pcdh18-interacting partner Dab2
whose expression was also validated by RT-PCR. pcdh18 belongs
to the cadherin superfamily: a large family of transmembrane
glycoproteins that mediate calcium-dependent, homophilic cell-
cell adhesion. Interestingly, the analysis revealed the expression of
more than 250 additional glycoproteins in the same cluster.
Among these glycoproteins are CD55, Masp1, Nfam1, IL12A,
P2RX7, P2X, Thbs1 and TLR4, genes that are implicated in
activation of immune response. In addition, nearly 25% of the
genes that belong to this cluster are classified as ‘‘membrane’’
genes and are also likely to participate in cell activation. Notably,
31 genes of this cluster are classified as ‘‘cell cycle’’ genes
including: Cdca2, Bub1, Cdc25c, E2f2, Cyclin D1, Fgfr2, and
Fgf10 (and another 12 genes are classified as ‘‘M phase’’ genes).
The concomitant expression of both pcdh18 – a mediator of TCR-
signaling, and mitogenic genes that initiate cell cycle entry,
suggests that pcdh18 may be influential in cell cycle entrance.
Additional studies will reveal whether pcdh18 activation is cell
cycle dependent. Furthermore, cell cycle entry of activated
nonlytic TIL is typically followed by AICD [6]. Indeed, GO
functional analysis of the early transcriptional response to Cm
activation (cluster 2, genes that up-regulate 4 and 6 hours after
activation) reveals strong enrichment of apoptotic genes in this
cluster, among them the apoptotic facilitator BCL2-like 14, IFN,
TNF and lymphotoxin A (Figure S7).
In Fig. S8 we also analyzed the array results for cluster
distribution of ISR that have been shown to be expressed in T cells
[16]. There are 8 ‘active’ ISR genes (defined as having the highest
coefficient of variation; .15% of total) and 17 ‘non-active’ ISR
genes expressed in activated Cm cells (this designation means that
while expressed, the relative change in expression for this group is
modest- having the lowest 85% of CV). Thus, 25 ISR genes are
expressed during Cm cell conversion into Em cells which could
potentially function to modulate proximal TCR signaling. This list
includes several well-characterized ISR: PD-1, 2B4, CTLA-4,
PEACAM (CD31), CEACAM-1 (CD66a), and CD85. RNA
encoding a major ISR PD1 is expressed in freshly-isolated CD4
+
TIL but not in CD8
+ TIL (Fig. 2d). Upon activation of CD8
+ TIL
in vitro both PD-1 and its ligand PD-L1 are briskly upregulated
with kinetics similar to GrzB. We interpret these data to mean that
freshly-isolated TIL are nonlytic and express pcdh18 but not PD-1
RNA. In spite of upregulation of TIL PD-1 expression upon
activation in vitro, if rested in vitro before activation, TIL regain lytic
function diminishing a role for PD-1 in the nonlytic phenotype.
Gene array analysis showed that ‘exhausted’ CD8
+ T cells that
develop in response to persistent antigen load, are distinct from
other T cells in different activation states, including anergic cells,
and one gene prominently expressed in exhausted cells is PD-1
[19]. Since PD-1 RNA is not expressed in either nonlytic CD8
+
TIL (Figure 2) and expression in Cm cells from aged mice is
modest in comparison to Em cells (Fig. S3), exhausted cells appear
to be distinct from both Cm cells and nonlytic TIL. Interestingly,
upon activation PD-1 is transcribed in both cell types and with
Figure 5. Protocadherin qRT-PCR and gene array analyses in activated Cm cells. (5a) pcdh18 qRT-PCR analysis of FACS-purified Cm and Em
cells from young, aged, or ‘memory’ mice (from Fig. 4d) was as indicated (bottom panels). Gene array of FACS-purified Cm cells from a pool of 10
aged mice was performed by the NYU Center for Health Informatics and Bioinformatics. Purified Cm were activated in vitro and total cells in each
culture were isolated for RNA extraction. cDNAs were hybridized to GeneChip arrays using an Affymatrix platform and the data were processed as
described in Materials and Methods. (5b) Bone marrow CD8
+ T cells were purified by positive selection magnetic immunobeading from young or
aged mice, activated in vitro with ConA, and qRT-PCR performed as before.
doi:10.1371/journal.pone.0036101.g005
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+,P I
hi cells are
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GrzB, IL-2, TNF) (Fig. S9) [11,12]. A further distinction between
nonlytic TIL and exhausted T cells is the rapidity with which TIL
regain proximal TCR signaling and lytic function- within 2 h of
purification [5]. However, exhausted T cells require dramatically
longer to regain function (typically requiring PD-1 blockade [20])
and dysfunctional anergic T cells are thought to be very difficult to
functionally recover.
As has been hypothesized previously, control of activation of the
adaptive T cell immune response is tightly regulated by the activity
of potentially a large number of ISR [16,18]. Most ISR function as
cell surface adaptor proteins that are themselves activated by an
activating signal delivered to the cell (Ag recognition) and which
function by recruiting an inhibitory phosphatase into proximity to
its targets, often including the kinase responsible for activation of
the ISR [17]. The rapidity and phenotype of inhibition of TCR
signaling mediated by pcdh18 is characteristic of ISR expressed in
immune cells which, although it differs from most ISR in lacking
an ITIM motif and is activated by homophilic interaction in trans
[21], functions equivalently (by binding directly to p56
lck) in the
inactivation of proximal TCR signaling. Like other ISR (e.g. PD-
1), pcdh18 is transcriptionally regulated upon activation of
memory cells. Thus, in Cm cells where pcdh18 RNA is relatively
low, functional inhibition of TCR signaling can occur after gene
expression.
Expression of several dozen ISR genes during activation of Cm
raises the question how Cm cells can be efficiently activated? The
fact that Cm cells are rapidly activated and expand in vivo upon re-
exposure to antigen supports the notion that either: not all ISR
transcripts are translated, that the encoded proteins are unable to
function, or the inhibitory signal is superseded by the activation
signal. It is also possible that ISR ligands are not expressed on
APC during Cm re-activation thus Ag-dependent activation is
unimpeded. The notion that multiple ISR are expressed upon T
cell activation but the availability of any given ligand controls ISR
activity is supported by the observations that dendritic cells and
endothelial cells can express ligands for multiple ISR [22,23] and
tumors commonly express ISR ligands (e.g. MCA38 tumors
express pcdh18, B7-1 [24] and possibly additional ISR ligands).
Such redundancy in this system that restricts effector T cell
function argues its physiological importance in governing the
response to re-activation of the memory response.
Collectively, (as shown diagrammatically in Fig. S10) our
observations suggest that upon activation of CD8
+ memory cells,
pcdh18 interacts with p56
lck and that the binding of p56
lck by
pcdh18 is causal to the failure to activate ZAP70 and subsequent
deficient effector phase function. Thus, we have identified a novel
p56
lck binding protein that functions as an inhibitory signaling
receptor during the effector phase in activated memory cells.
pcdh18 is not only an inhibitory signaling receptor that can arrest
the effector phase, but it is the first described marker that uniquely
identify CD8
+ T cells of memory origin.
Materials and Methods
Mice
C57BL/6 male mice were obtained from Jackson Laboratories
(Bar Harbor, ME), were housed five per cage in a barrier facility,
and were maintained on a 12 hr light/dark cycle (7 AM to 7 PM)
with ad libitum access to food and water. A sentinel program
revealed that tumor-bearing mice were Murine Hepatitis Virus-
negative. Experiments involving animals were conducted with the
approval of the New York University School of Medicine
Committee on Animal Research.
Tumors
MCA38 adenocarcinoma [5,7] (a gift of Nick Restifo, National
Cancer Institute) was passaged from tissue culture plasticware by
incubation in HBSS containing 3 mM EDTA followed by washing
in HBSS. Cell viability was determined by Trypan Blue dye
exclusion and 1–2610
5 cells were injected intraperitoneally in a
volume of 0.1 ml of HBSS for tumor induction. Cells were
passaged in vitro for 3–5 weeks following which new frozen stocks
were thawed for usage.
Tissue culture
RPMI-1640 medium (Biowhittaker, Walkersville, MD) was used
for growth of MCA-38 cells and for culture of T cells as described
[6]. Thymoma EL-4 (ATCC) was passaged by dilution of media
and CTLL-2 cells were maintained in media supplemented with
rIL-2.
Isolation of cells
Tumors were dissected, mechanically disrupted by passage
through a tissue press, digested into single cell suspensions using
collagenase, and TIL were isolated by immunomagnetic separa-
tion using type LS
+ columns and anti-CD8a (or anti-CD4)
conjugated magnetic beads (Miltenyi Biotec, Auburn, CA) as
described previously [6]. Aliquots of isolated T cells were analyzed
by flow cytometry and were routinely ,95% CD8
+. TIL were
used immediately after isolation for experiments (‘non-lytic’)
except in some experiments where TIL were plated in complete
RPMI-1640 medium (,2610
6 cells/ml) for 6–18 h before usage
(‘lytic’). In some experiments TIL were further purified by FACS.
Splenocytes and bone marrow cells were usually enriched for
CD8
+ T cells by negative selection magnetic immunobeading
(Miltenyi Biotec) followed by FACS. In some experiments
splenocytes were labeled with anti-CD11c, B220, CD4 or CD8
and sorted using a MoFlo Legacy high-speed sorter. Cells were
collected in media and immediately reanalyzed for purity in a
LSR–II cytometer. Cells were collected and placed in Trizol
immediately for RNA isolation and RT-PCR.
,40% CD8
+ (top panel). .70% of CD8
+CD44
hi cells are CD62L
hiCD127
hi (bottom panel). (6b) (top) Reciprocal immunoblot of p56
lck isolated from
nonlytic TIL. Analysis was performed as described in Figure 1a (after conjugation with cognate MCA38 tumor cells for 0, 5, or 15 min as indicted and
immune precipitated with anti-p56
lck Ab 2102- left panels- or Ab 3A5- right panels) and blots were probed with anti-pY or anti-Pcdh18 as indicated.
(bottom) Expression of pcdh18 protein in transfected effector cells by flow cytometry was as described in ‘Materials and Methods’. Cells were stained
with control or anti-pcdh18 Ab as indicated (top). (6c) Phase contrast microscopy of transfected cells. Effector cells were transfected as indicated and
cultured in vitro in the presence or absence of IL-2 for ,24 h before microscopy. Arrows indicate cell clusters. (6d) RNA was extracted from
transfected effector cells (‘control’ or ‘pcdh18’), nonlytic TIL (‘TIL 0 h’), or lytic TIL that were activated with anti-CD3 for 4 hours (‘TIL 24 h’) and used
for cytokine qRT-PCR, or cells were assessed for viability (PI and Annexin V staining), as described in ‘Materials and Methods’. In the viability assay two
different plasmid constructs were used in separate experiments (bottom left panel) or the Y842F mutant (bottom right panel). (6e) Transfected
effector cells were assayed for lytic function by re-directed cytolysis assay as described in ‘Materials and Methods’. (6f) Transfected cells were assayed
for binding of anti-Zap70 pY493 after permeabilization following activation with anti-TCR for 2 min as described in ‘Material and Methods’.
doi:10.1371/journal.pone.0036101.g006
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Primers were designed with restriction sites that are absent
within Pcdh-18 for cloning into pIRES (SacI and XmaI). The
primers used were, Pcdh-18-SacI-Forward: 59 TTGAGCTCT-
GAGTGGCTGGAGGA, and Pcdh-18-XmaI-Reverse: 59
TTCCCGGGACACCTCGGGATCTTC. A 28-cycle RT-PCR
using cDNA generated from lung as a template and a high fidelity
Taq (Phusion Taq, Life Technologies) generated a 3.4 Kbp
product. The band was extracted from an agarose gel and purified
using the ‘PCR clean up kit’ (Denville). pcdh-18-pIRES was then
digested with SacI and XmaI, the products separated in an
agarase gel, and the linear plasmid was extracted and purified.
The plasmid was dephosphorylated and ligated to the PCR
product (Ligation Kit, Life Technology) and used to transform
DH5a. A selected clone was subjected to restriction digestion to
confirm the presence of pcdh-18 which was also confirmed by
DNA sequencing.
Generation of a pcdh-18 point mutant (Y842F)
PCR primers were selected with restriction sites that are present
within pcdh-18, KpnI (cDNA nucleotide 2287) and SspI (cDNA
nucleotide 2557). The primers used were, pcdh-18-Y842-Forward:
59 CACCAGGGGCAATTTCAGCCACGGCCA, and pcdh-18-
Y842-Reverse: 59 AAGCATGGAGAGAAGCTGCGA-
GACCTC. The forward primer contains the mutated nucleotide
(in bold T instead of an A) that generated the single point mutation
in the product. A 30-cycle PCR using pcdh-18-pIRES as a
template and a high fidelity Taq polymerase (Phusion Taq, Life
Technologies) generated a 270 bp product. The band was
extracted from an agarose gel and purified using ‘PCR clean up
kit’ (Denville). pcdh-18-pIRES was digested with KpnI and SspI.
The digested products were separated in an agarose gel and the
linear plasmid was extracted and purified. The plasmid was
dephosphorylated and ligated to the PCR product (Ligation Kit,
Life Technology) and used to transform DH5a. A selected clone
was subjected to restriction digestion to confirm the presence of
pcdh-18 and confirmed by sequencing.
Transfection of primary CD8
+ T cells
Splenocytes were isolated, plated in complete media at 5610
6
cells supplemented with 10% of conditioned media from 2C11
hybridoma. After 36 h cells were collected and re-plated at 2610
6
cells/well supplemented with 10% of conditioned medium from
an IL-2 producer line. 0.008 mg of plasmids was used to transfect
by nucleofection (using program X-001, Lonza). Cells were
cultured for 4 h in complete media containing IL-2. For signaling
experiments, cells were then cultured in RPMI medium lacking
IL-2 and FBS for 3–4 h prior to any experiment.
Gene Array sample preparation
Ten spleens were pooled from 62 week old C57BL/6 male mice
and enriched for CD8
+ T cells by negative selection using a
cocktail of biotinylated antibodies to deplete CD4, CD11c,
CD11b, MHC-II, B220, and NK cells. Cells were then stained
for CD8, CD44, CD62L, and CD127 and sorted (using a iCyt
Reflection parallel cell sorter). Cells were collected and cultured
(0.5610
6 cells/well) in 10% complete RPMI media supplemented
with 0.005 ugr Con A and RNA prepared using TRIZOL and the
‘RNeasy clean-up kit’ (Invitrogen) after activation for different
times.
We established transcriptional profiles for 6 time points after T
cell activation (4, 6, 8, 16, 20, 24 h) including a zero h time point
(prior to activation). RNA was isolated by standard procedures and
its quality was assessed by the NYU Center for Health Informatics
and Bioinformatics. cDNAs were hybridized to GeneSpring arrays
using the mouse genome MOE430 2.0 array (Affymetrix) which
interrogates ,45,000 transcripts. The data discussed in this
publication have been deposited in NCBI’s Gene Expression
Omnibus and are accessible through GEO Series accession
number GSE34618.
Analysis of gene expression data
Utilizing GeneSpring 7.2 (Agilent), raw Affymetrix CEL files
were processed and normalized by applying the Robust Multi-
Array Average expression measure (RMA) and baseline scaling.
These metrics were further filtered to obtain 35,160 ‘‘valid genes’’,
representing transcripts (gene probes) that were detected as
‘‘Present’’ in at least one sample across all tested time points. To
obtain a subset of variable genes, we calculated the coefficient of
variation (CV) for each transcript and generated a set of 5274
‘‘active genes’’ containing the transcripts with the highest (15% of the
total) CV scores. For discovering prominent expression patterns
we used the EXPANDER program [25] and executed CLICK, a
novel clustering algorithm [26] that makes no prior assumptions
on the structure or the number of the clusters. CLICK discovered
five unique expression patterns. Cluster 4 has a unique undulating
kinetics and includes pcdh18 that peaks twice within 24 h. We
utilized functional annotations of murine genes provided by the
Murine Genome Informatics, which uses the standard vocabulary
introduced by the Gene Ontology (GO) consortium. Enriched
functional categories (p#0.01, after correction for multiple testing)
were identified in each of the gene sets using EXPANDER, in
which hypergeometric calculation is used to determine over-
represented GO functional categories in a target set relative to a
background set (the entire collection of putative murine genes)
[27]. To avoid biases, genes represented by multiple probe sets
were counted only once.
Quantitative RT-PCR analysis
Total RNA was isolated (Trizol), converted into cDNA using
Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA),
and was analyzed by real-time PCR (‘SYBR Green PCR master
mix’, Applied Biosystems, Carlsbad, CA) using 200 fmol/uL
primer concentration for 40 cycles. SYBR incorporation into
PCR products was monitored using a model 7500 real-time PCR
system (AB). Dissociation curve analysis (SDS 2.0 software)
assessed the specificity and integrity of the PCR products.
Degradation of total RNA used in the cDNA synthesis was
normalized by determining the threshold cycle (Ct) values for
target genes and housekeeping genes (b-actin and GAPDH) in
each sample. Target gene/housekeeping gene ratios were cal-
culated as: ratio=2
[Ct(housekeeping)2Ct(target)]. Relative mRNA
levels are expressed as ‘fold induction’ for samples at different
times of activation with ConA compared to time ‘0’ (ca 2–72 hr).
PCR reactions were conducted in triplicate and repeated at least
once with unique samples.
Primers used were: Pcdh18, Pcdh12, Pcdh8, IL-2, TNF, IFN, b-
actin, GAPDH, granzyme B, PD-1, PD1-L, Dab1, Dab2a, Dab2b
(sequences provided in Supplement).
Antibodies
Antibodies, reagents, and procedures used in immunoblotting
and flow cytometry were as described previously [5]. Additional
Ab used were: phospho-p56
lck (Ab Y505/527, Cell Signaling
Technology, Beverly, MA), phosphotyrosine (clone 4G10, Cell
Signaling Technology, Beverly, MA), p56
lck (mouse Ab 3A5; Santa
Cruz Biotechnology), p56
lck (Ab 2102; Santa Cruz Biotechnology),
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protein containing the cytoplasmic domain of Pcdh18 and
hyperimmunization of rabbits. Rabbit anti-pcdh18 with a similar
specificity was also purchased (HPA017976, Sigma Chemical
Company, St. Louis, MO).
Flow cytometric analysis
All analyses were performed in general as described previously
[5]. Primary Ab were added to cells (10
6/mL) at empirically
determined optimal concentrations. After incubation at 4u for
20 min, cells were washed once with 1 ml of FACS wash (PBS, 2%
FBS) and fixed with 1% paraformaldehyde before analysis. For
analysis of intracellular molecules, cells were first fixed and
permeabilized using BD cytofix/Cytoperm (BD-bioscience). When
used, secondary antibodies were diluted in the perm-wash buffer.
Species-matched, control primary Ab was used to determine
parameters and settings for flow cytometry.
T cell activation
TIL (or activated primary splenocytes 4 h after transfection)
were isolated and incubated in serum-free RPMI1640 medium for
3 h, washed, resuspended in cold compete medium, and anti-
CD3e added for 30 min. Samples were collected and resuspended
in warm medium containing anti-hamster Ig for 1, 2, or 5 min
before preparation of detergent extracts or fixation for flow
cytometry for staining with activation-specific anti-Zap70.
Calcium flux
After transfection of primary spleen cells as described above,
cells were incubated in 1%FBS RPMI1640 containing with
0.001 mg/mL biotinylated anti-CD3, 0.001 mg/mL biotinylated
anti-CD8b, anti-CD8 PE, 0.0032 mg/mL Indo-1 AM
(eBioscience) and 2 mM Probenecid (Sigma) for 30 minutes at
RTu in the dark. Samples were washed twice with serum-free
RPMI, then resuspended at 1610
7 cells mL. Cells were
equilibrated to 37u five min before reading on a LSRII and were
activated by crosslinking with 0.0125 mg/mL of streptavidin
(Pierce).
Listeria monocytogenes
Listeria monocytogenes (wt and recombinant expressing ova, a gift
of Eric Pamer, MSKCI) were grown in BHK media and diluted in
PBS for mouse injection (iv). A dose of 5–10610
3 bacteria was
sufficient to induce infection in wt mice which was cleared in 3–4
days as assessed by colony formation on agar plate of extracts of
various organs.
Chromium-release assay
Cytolysis activity of TIL or transfected primary lytic effector
cells was assessed in standard re-directed [
51Cr]-release assays
using P815 cells performed in quadruplicate wells for each E:T
ratio exactly as described [14]. Maximal release from target cells
was determined by treatment of cells with 1% Triton X-100,
spontaneous release was determined from cultures of labeled target
cells incubated with medium only, and the formula used for
determination of specific lysis was: (experimental release -
spontaneous release)/(maximal release - spontaneous re-
lease)6100.
Supporting Information
Figure S1 (a) pcdh18 PCR of fractionated spleen, related to
Figure 2. Spleens from aged mice were used for analysis of pcdh18
expression. Single cells were prepared by mechanical disruption by
grinding between the ends of frosted glass microscope slides in PBS
followed by collection of fibrous material by settling at 16 g for
2 minutes. Cells in suspension were recovered by centrifugation,
washed in PBS, and rbc lysed in hypotonic solution. Samples for
analyses were: the non-manipulated organ (‘whole spleen’), fibrous
material that was recovered by settling of the initial cell suspension
at 16 g (‘capsule enriched’), cells taken immediately after
mechanical disruption of spleen tissue into single cell suspension
(‘disrupted spleen’), and cells of the single cell suspension following
removal of the ‘capsule enriched’ fraction and lysis of erythrocytes
(‘disrupted spleen (rbc lysed)’). (b) qRT-PCR and pcdh18 qRT-
PCR primer efficiency. Spleen or bone marrow cells were
harvested, enriched for either CD4
+ or CD8
+ T cells by negative
selection as described above followed by staining with CD8,
CD44, CD62L, and CD127 Ab. In some experiments other cell
types (fractionated spleen preparations, CD4
+ or CD8
+ TIL
isolated from MCA 38 tumors, total spleen CD8
+ T cells, bone
marrow-derived dendritic cells, or spleen NK cells) were analyzed
after magnetic immunobead and/or FACS purification. (c)
pcdh18 is induced by LPS treatment of bone marrow-derived
DC. DC were prepared from bone marrow of C57BL/6 mice by
standard methods [28] and either activated by overnight treatment
with LPS or not before RNA isolation and analysis.
(TIF)
Figure S2 TIL qRT-PCR analyses, related to Figure 2.
Single cell suspensions of MCA38 tumors were prepared and
CD4
+ or CD8
+ TIL were isolated by magnetic immunobeading.
All data are from freshly-isolated, nonlytic TIL. NK cells were
isolated by magnetic immunobead positive selection from spleens
of control or mice treated 24 h prior with Poly I:C as indicated.
TIL were labeled with anti-CD4 or CD8 Ab and further purified
by FACS (example of flow cytometry analysis shown in Figure 2)
before RNA isolation and qRT-PCR analysis. Data shown are
from a single experiment of two.
(TIF)
Figure S3 qRT-PCR analyses of FACS-purified Cm and
Em cells from young, aged, or ‘memory’ mice, related to
Figure 3. Central memory cells were isolated by FACS from
young (5 week), old (1 year), or memory (infected with Listeria
monocytogenes at 7–8 weeks of age and recovery until 1 year old)
mice. Cells were activated in vitro for the indicated times and then
purified by FACS into CD62L
hi (‘Cm’) or CD62L
lo (‘Em’) cell
populations which provided RNA for qRT-PCR analyses.
(TIF)
Figure S4 (a) AT of TIL into RAG mice, related to Figure 4.
CD8
+ T cells were isolated by FACS from either pooled seven
week old control mice spleens or as TIL from 7 week old mice
bearing MCA38 tumors for two weeks. 2610
6 purified cells were
adoptively transferred to RAG2/2 mice (n=6). Three months
after transfer, spleen CD8
+ T cells were isolated by magnetic
immunobeading (,2610
6 cells per mouse) and analyzed by RT-
PCR before or after activation in vitro (0.005 mg/mL ConA for
20 h) as indicated. (b) Analysis of proximal TCR signaling in
CD8
+ Cm and naive effector cells of aged mice. Spleen cells were
isolated from an aged control mouse, activated with either anti-
CD3/CD8 crosslinking for different times (for calcium flux) or
anti-CD3e (for Zap70 analysis), then assayed for activation as
described in ‘Methods’.
(TIF)
Figure S5 Microarray analysis of Cm cells, related to
Figure 5. Purified Cm cells were activated in vitro with Con A for
the indicated times before cells were taken for RNA isolation and
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obtain a subset of variably expressed genes, we calculated the
coefficient of variation (CV) for each of the ‘‘valid genes’’ (see
Material and Methods) and generated a set of 5274 ‘‘active genes’’
containing the transcripts with the highest (15% of the total) CV
scores. For discovering prominent expression patterns we used the
EXPANDER program [25] and executed CLICK, a novel
clustering algorithm [26] that makes no prior assumptions on
the structure or the number of the clusters. CLICK discovered five
unique expression patterns.
(TIF)
Figure S6 The normalized expression array data of all
‘‘active genes’’ are shown. For each time of activation values
for the probe-set signal and the assigned detection (Present/
Marginal/Absent) are given. The ‘‘active genes’’ were further
sorted in each cluster based on their CV score to present the most
variable genes at the very top of each grouping.
(XLS)
Figure S7 Presented is the David GO functional analy-
sis. Genes were classified into functional groups using the GO
annotation tool [29] and overabundance was calculated using
EASE software [29]. Functional classification of genes with an
EASE score lower than 0.05 were marked as overabundant and
included in the figure.
(XLS)
Figure S8 Expression in activated Cm cells of ISR genes
known to be expressed in T cells ([16,17] was analyzed.
The data is presented in the top part of the figure for ISR that are
‘‘active’’ (having variable expression patterns- Fig. 5) and ‘‘non-
active’’ genes (with relatively constant expression patterns) are
shown in the bottom part of the figure. (Only transcripts with the
highest 15% of the total CV sores were assigned into expression
pattern clusters, thus ISR that having ,85% CV have no cluster
assignment).
(XLS)
Figure S9 Gene array expression data for selected genes
expressed in Cm cells upon activation. Relative expression
at different times of activation of selected genes for which PCR
validation is available (In figure S3) is shown.
(TIF)
Figure S10 Schematic of p56
lck regulation involving
pcdh18, related to Figure 1. This updated model differs from
that shown in Figure1b in accommodating our data that shows
that p56
lck Y505 is not phosphorylated upon activation of TIL
and, likely also in memory CD8
+ T cells since Zap70 is not
activated in primary CD8
+ T cells transfected to express pcdh18
[5]. In this model pcdh18 homophilic interactions between TIL
and cognate MCA38 tumor disrupt TCR mediated signaling by
binding to p56
lck. Binding of p56
lck to pcdh18 causes a
conformational change that prevents Csk (which localizes at the
immune synapse with p56
lck [7]) from phosphorylating the p56
lck
Y505 motif and thus permits phosphorylation of the homologous
motif in pcdh18 (Y842). p56
lck-Y384 is then available for targeting
by Shp-1 causing p56
lck to deactivate as observed [5]. Thus,
inactivation of p56
lck results in the inability to activate ZAP70, in
turn preventing propagation of proximal signaling and loss of
effector phase lytic function. The second diagram shows pcdh18
expressed in nonlytic TIL (or Em cells) engaged in homophilic
interaction with pcdh18 expressed in a target cell; either tumor,
endothelial cell, or potentially an activated DC. We propose the
testable hypothesis: as a consequence of homophilic binding,
recruitment of T cell pcdh 18 into proximity with Csk permits
phosphorylation at Y842. Y842 phosphorylation in turn either
permits or enhances binding to p56
lck leading to inactivation of
kinase function or sequestration from its cognate targets TCRz or
Zap70.
(TIF)
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